SCHEMBL22367696

SCHEMBL22367696

OC1Cc2c[c]ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL318422 0.81 PGR (0.36) —
SCHEMBL4142319 0.78 PGR (0.39) —
SCHEMBL1450405 0.73 — —
SCHEMBL18345450 0.70 — —
SCHEMBL4065727 0.69 — —
SCHEMBL4063260 0.69 — —
SCHEMBL16870529 0.69 GRIN2D (0.45) —
SCHEMBL12228571 0.69 — —
SCHEMBL1451016 0.68 PGR (0.33) —
SCHEMBL5401407 0.68 TDP1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3700906-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Prelude Therapeutics, Incorporated (US) 2020-09-02 — — EP claimed
EP-3700906-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Prelude Therapeutics, Incorporated (US) 2020-09-02 — — EP disclosed
Send feedback